Several possible studies
Story checked
Leica biosystems integrates tempus AI into aperio AI store (opens in a new tab)
news-medical.net · 2026-09-25
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Leica biosystems integrates tempus AI into aperio AI store
news-medical.net · 2026-09-25
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedLeica Biosystems announced the addition of two Paige digital pathology AI-enabled products from Tempus to its Aperio AI Store.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 5Not checkedThe new offerings include Paige PanCancer Detect, described as a research application designed to identify suspicious areas across more than 40 cancer types, powered by Tempus’ pathology foundation model.View evidenceHide evidence
As statedmore than 40 cancer types
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 5Not checkedThe release also includes Paige Prostate, a suite of AI-powered research applications supporting assessment of prostate cancer features in H&E-stained whole-slide images.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 5Not checkedLeica Biosystems says the Aperio AI Store is designed to simplify and scale AI adoption by integrating partner algorithms into the Aperio HALO AP workflow, and that both new products are for research use only and not intended for diagnostic or clinical use.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 5Not checkedCompany executives said the collaboration is intended to make advanced image analysis more accessible, seamless, and actionable for oncology research.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Crossref, Europe PMC · 15 candidate papers
Precision Diagnostics in Prostate Cancer: Integrating Biomarkers, Imaging, Genomics, and Artificial Intelligence in Contemporary United States Practice.
Medical Sciences (Basel, Switzerland) · 2026 · PubMed
Implementation of a digital pathology workflow
Advances in Digital Pathology and Artificial Intelligence in Pathology · 2027 · Crossref
Insights into artificial intelligence-based digital pathology in hepatobiliary and pancreatic cancer.
Frontiers in Oncology · 2026 · PubMed, Europe PMC
Clinical applications of artificial intelligence in genitourinary pathology.
Molecular Aspects of Medicine · 2026 · PubMed
Artificial Intelligence–Aided Diagnosis of Breast Cancer Lymph Node Metastasis on Histologic Slides in a Digital Workflow
Modern Pathology · 2023 · Crossref
And 10 more candidates considered.